ACA health insurance enrollments down 1.2M amid premium increases

ACA individual-market enrollments fell by roughly 1.2 million year-over-year to about 22.97 million policies purchased during the open enrollment period that ended Jan. 15, with 19.59 million returning policyholders and 3.38 million new enrollees. The decline is attributed to the expiration of temporary premium subsidies (ended Dec. 31, 2025), which coincided with significant rate increases — in some cases doubling or tripling — and prompted debate among federal lawmakers over extending subsidies and potentially reopening enrollment. A legislative extension or reopening could materially reverse the enrollment drop and affect insurer revenue and state exchange dynamics, while continued subsidy lapse risks higher uninsured rates and pressure on affordability.

Analysis

Market structure: A ~1.2M decline (~5% vs prior 24.2M) in ACA enrollments and expiration of subsidies shifts economic rents away from small, exchange-focused carriers toward large diversified players. Direct losers: high-exposure exchange carriers (Centene, Molina, regional plans) facing adverse selection and margin pressure; winners: diversified managed-care/PBM players (UnitedHealth UNH, CVS Health CVS, Elevance ELV) with Medicare Advantage and commercial scale to absorb volatility. Smaller carriers will likely raise 2026 premiums, accelerating exits and consolidation over 6–18 months, increasing pricing power for survivors.

Risk assessment: Key tail risks are binary—(A) Congress extends subsidies and reopens enrollment within 30–90 days (material upside to exchange volumes and to smaller carriers), or (B) prolonged subsidy lapse increases uncompensated care and state budget stress, pressuring municipal hospital credits. Hidden dependencies include state reinsurance programs, Medicaid churn, and Q1 insurer guidance cadence (earnings calls late Apr–May). Catalysts: congressional vote timing, CMS reopen announcements, and Feb–May insurer reserve updates.

Trade implications: Expect near-term equity volatility and idiosyncratic dispersion across insurers; favor capital-efficient option structures for convexity. Short biased trades on CNC and MOH (3–6 month horizon) and long positions in UNH/CVS as defensive/scale exposure. Monitor claims/loss-ratio commentary in Q1 filings and CMS enrollment updates—close/trim positions if enrollment reopens adding >500k within 30 days.

Contrarian angles: Market may be overpricing a permanent collapse in exchange economics; a subsidy extension is a high-impact, moderate-probability event that would trigger rapid mean reversion in small-cap insurer stocks. Use asymmetric option bets (small long-call exposure on beaten-up names) to capture the legislative binary while maintaining core delta-neutral relative positions.

Key Decisions for Investors

• Establish a 2.5% portfolio long in UnitedHealth (UNH) over 3–12 months to hedge sector consolidation risk; target entry $< UNH market price (scale in 1/3 tranches), take profit or reassess on +10% move or after Q2 earnings if loss ratios improve.
• Establish a 2% short exposure to Centene (CNC) and Molina (MOH) combined using 3-month put spreads (buy 1 7% OTM put / sell 1 14% OTM put) sized to limit capital at risk to ~2% portfolio; unwind if either stock rallies >10% or if Congress passes subsidy extension within 60 days.
• Implement a pair trade: long UNH (2%) / short CNC (2%) equal-dollar to capture relative margin resilience; rebalance if spread widens >5% or after CMS announces enrollment reopen (close within 7 trading days of that announcement).
• Allocate 0.5–1% to long 6-month call spreads on CNC or MOH (cheap upside) as asymmetric hedge against a subsidy-extension event; set max loss = premium paid, take profit if premium increases >200% or underlying rises >20%.